Salwan Al-Nasiry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Salwan Al-Nasiry has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
C. Luyten
3 shared publications- Geke Hasperhoven
Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands
3 shared publications - Johan Bulten
Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
3 shared publications M. Hanssens
3 shared publications- Manouk L. E. Hendrix
Department of Obstetrics & Gynecology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre (MUMC+)
3 shared publications R. Pijnenborg
3 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 45 (1)
Placental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population
- 12 November 2026
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 45 (1)
Open AccessPlacental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population
- Open Access
- 3 November 2025
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (4) , 671-679
Temporal Changes in Fetal and Maternal Parameters in Early‐Onset Fetal Growth Restriction: A Multicenter, Retrospective Cohort Study
Objective(s): Timing of birth is complex in early‐onset fetal growth restriction (FGR) and the literature is limited regarding the exact sequence of changes in antenatal parameters. This study aimed to examine this sequence in a large early‐onset FGR cohort. Design: Multicenter, retrospective cohort study. Setting: Six tertiary care hospitals in the Netherlands. Population: A post hoc analysis of the OPtimal TIming of antenatal COrticosteroids in early‐onset fetal growth REstriction (OPTICORE) study was performed. Methods: Repeated measures of antenatal parameters were assessed routinely from diagnosis to birth. Mixed‐effects models were used to determine the probability of abnormality (binary) and the trend (Z‐score, continuous) over time for each parameter (< 32 and ≥ 32 weeks). Main Outcome Measures: The time sequence of changes in fetal and maternal health parameters from diagnosis to birth in early‐onset FGR pregnancies. Results: A total of 1453 patients were included, of whom 1025 patients gave birth < 32 weeks and 428 ≥ 32 weeks, with median gestational ages of 29 + 3 weeks (IQR 27 + 6, 30 + 5) and 34 + 4 weeks (IQR 33 + 0, 37 + 0), respectively. The most apparent changes in fetal parameters in the last days preceding birth comprised: absent/reversed end‐diastolic velocity of the umbilical artery and cardiotocography abnormalities. Regarding maternal parameters, an increased probability of antihypertensive agent(s) use was seen shortly preceding birth < 32 weeks. Conclusion(s): This large cohort of early‐onset FGR pregnancies provides a time sequence of fetal and maternal health parameters from diagnosis to birth, which could inform clinical management.
- 3 November 2025
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 133 (4) , 671-679
Open AccessTemporal Changes in Fetal and Maternal Parameters in Early‐Onset Fetal Growth Restriction: A Multicenter, Retrospective Cohort Study
Objective(s): Timing of birth is complex in early‐onset fetal growth restriction (FGR) and the literature is limited regarding the exact sequence of changes in antenatal parameters. This study aimed to examine this sequence in a large early‐onset FGR cohort. Design: Multicenter, retrospective cohort study. Setting: Six tertiary care hospitals in the Netherlands. Population: A post hoc analysis of the OPtimal TIming of antenatal COrticosteroids in early‐onset fetal growth REstriction (OPTICORE) study was performed. Methods: Repeated measures of antenatal parameters were assessed routinely from diagnosis to birth. Mixed‐effects models were used to determine the probability of abnormality (binary) and the trend (Z‐score, continuous) over time for each parameter (< 32 and ≥ 32 weeks). Main Outcome Measures: The time sequence of changes in fetal and maternal health parameters from diagnosis to birth in early‐onset FGR pregnancies. Results: A total of 1453 patients were included, of whom 1025 patients gave birth < 32 weeks and 428 ≥ 32 weeks, with median gestational ages of 29 + 3 weeks (IQR 27 + 6, 30 + 5) and 34 + 4 weeks (IQR 33 + 0, 37 + 0), respectively. The most apparent changes in fetal parameters in the last days preceding birth comprised: absent/reversed end‐diastolic velocity of the umbilical artery and cardiotocography abnormalities. Regarding maternal parameters, an increased probability of antihypertensive agent(s) use was seen shortly preceding birth < 32 weeks. Conclusion(s): This large cohort of early‐onset FGR pregnancies provides a time sequence of fetal and maternal health parameters from diagnosis to birth, which could inform clinical management.
- Open Access
- 24 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107102
Placenta accreta spectrum disorders using standardised magnetic resonance imaging (MRI) descriptors; interobserver agreement and diagnostic accuracy
- 24 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107102
Open AccessPlacenta accreta spectrum disorders using standardised magnetic resonance imaging (MRI) descriptors; interobserver agreement and diagnostic accuracy
- Open Access
- 1 July 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (7) , 1537-1549
Placental Methylglyoxal in Preeclampsia: Vascular and Biomarker Implications
BACKGROUND: Preeclampsia is a multifaceted syndrome that includes maternal vascular dysfunction. We hypothesize that increased placental glycolysis and hypoxia in preeclampsia lead to increased levels of methylglyoxal (MGO), consequently causing vascular dysfunction. METHODS: Plasma samples and placentas were collected from uncomplicated and preeclampsia pregnancies. Uncomplicated placentas and trophoblast cells (BeWo) were exposed to hypoxia. The reactive dicarbonyl MGO and advanced glycation end products (N ε -(carboxymethyl)lysine [CML], N ε -(carboxyethyl)lysine [CEL], and MGO-derived hydroimidazolone [MG-H]) were quantified using liquid chromatography-tandem mass spectrometry. The activity of GLO1 (glyoxalase-1), that is, the enzyme detoxifying MGO, was measured. The impact of MGO on vascular function was evaluated using wire/pressure myography. The therapeutic potential of the MGO-quencher quercetin and mitochondrial-specific antioxidant mitoquinone mesylate (MitoQ) was explored. RESULTS: MGO, CML, CEL, and MG-H2 levels were elevated in preeclampsia-placentas (+36%, +36%, +25%, and +22%, respectively). Reduced GLO1 activity was observed in preeclampsia-placentas (−12%) and hypoxia-exposed placentas (−16%). Hypoxia-induced MGO accumulation in placentas was mitigated by the MGO-quencher quercetin. Trophoblast cells were identified as the primary source of MGO. Reduced GLO1 activity was also observed in hypoxia-exposed BeWo cells (−26%). Maternal plasma concentrations of CML and the MGO-derived MG-H1 increased as early as 12 weeks of gestation (+16% and +17%, respectively). MGO impaired endothelial barrier function, an effect mitigated by MitoQ, and heightened vascular responsiveness to thromboxane A2. CONCLUSIONS: This study reveals the accumulation of placental MGO in preeclampsia and upon exposure to hypoxia, demonstrates how MGO can contribute to vascular impairment, and highlights plasma CML and MG-H1 levels as promising early biomarkers for preeclampsia.
- 1 July 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (7) , 1537-1549
Open AccessPlacental Methylglyoxal in Preeclampsia: Vascular and Biomarker Implications
BACKGROUND: Preeclampsia is a multifaceted syndrome that includes maternal vascular dysfunction. We hypothesize that increased placental glycolysis and hypoxia in preeclampsia lead to increased levels of methylglyoxal (MGO), consequently causing vascular dysfunction. METHODS: Plasma samples and placentas were collected from uncomplicated and preeclampsia pregnancies. Uncomplicated placentas and trophoblast cells (BeWo) were exposed to hypoxia. The reactive dicarbonyl MGO and advanced glycation end products (N ε -(carboxymethyl)lysine [CML], N ε -(carboxyethyl)lysine [CEL], and MGO-derived hydroimidazolone [MG-H]) were quantified using liquid chromatography-tandem mass spectrometry. The activity of GLO1 (glyoxalase-1), that is, the enzyme detoxifying MGO, was measured. The impact of MGO on vascular function was evaluated using wire/pressure myography. The therapeutic potential of the MGO-quencher quercetin and mitochondrial-specific antioxidant mitoquinone mesylate (MitoQ) was explored. RESULTS: MGO, CML, CEL, and MG-H2 levels were elevated in preeclampsia-placentas (+36%, +36%, +25%, and +22%, respectively). Reduced GLO1 activity was observed in preeclampsia-placentas (−12%) and hypoxia-exposed placentas (−16%). Hypoxia-induced MGO accumulation in placentas was mitigated by the MGO-quencher quercetin. Trophoblast cells were identified as the primary source of MGO. Reduced GLO1 activity was also observed in hypoxia-exposed BeWo cells (−26%). Maternal plasma concentrations of CML and the MGO-derived MG-H1 increased as early as 12 weeks of gestation (+16% and +17%, respectively). MGO impaired endothelial barrier function, an effect mitigated by MitoQ, and heightened vascular responsiveness to thromboxane A2. CONCLUSIONS: This study reveals the accumulation of placental MGO in preeclampsia and upon exposure to hypoxia, demonstrates how MGO can contribute to vascular impairment, and highlights plasma CML and MG-H1 levels as promising early biomarkers for preeclampsia.
- Open Access
- 8 March 2023
- Published by Springer Nature in Reproductive Health
- Vol. 20 (1) , 1-16
Effect of COVID-19 on antenatal care: experiences of medical professionals in the Netherlands
Background: COVID-19 has greatly affected the delivery of all health care services globally. Antenatal care is one area of care that has been impacted, despite the fact that attending antenatal check-ups is essential for pregnant women and cannot be postponed. Little is known about how exactly ANC provision has changed in the Netherlands, or how the changes have impacted midwives and gynaecologists providing those services. Methods: This study used a qualitative research design to investigate changes in individual and national practice following the onset of the COVID-19 pandemic. The study involved a document analysis of protocols and guidelines for ANC provision to evaluate how those changed following the onset of the COVID-19 pandemic and semi-structured interviews with ANC care providers (i.e., gynaecologists and midwives). Results: Guidance was issued by multiple organizations, during the pandemic, on how to approach the risk of infection in pregnant women, recommending several changes to ANC to protect both pregnant women and ANC providers. Both midwives and gynaecologists reported changes in their practice. With less face-to-face consultations happening, digital technologies became critical in the care of pregnant women. Shorter and fewer visits were reported, with midwifery practices adjusting their guidelines further than hospitals. Challenges, with high workloads and lack of personal protective equipment were discussed. Conclusions: The COVID-19 pandemic has had an immense impact on the health care system. This impact has had both negative and positive effects on the provision of ANC in the Netherlands. It is important to learn from the current COVID-19 pandemic and adapt ANC, as well as health care systems as a whole, to be better prepared for future health crises and ensure continuous provision of good quality care.
- 8 March 2023
- Published by Springer Nature in Reproductive Health
- Vol. 20 (1) , 1-16
Open AccessEffect of COVID-19 on antenatal care: experiences of medical professionals in the Netherlands
Background: COVID-19 has greatly affected the delivery of all health care services globally. Antenatal care is one area of care that has been impacted, despite the fact that attending antenatal check-ups is essential for pregnant women and cannot be postponed. Little is known about how exactly ANC provision has changed in the Netherlands, or how the changes have impacted midwives and gynaecologists providing those services. Methods: This study used a qualitative research design to investigate changes in individual and national practice following the onset of the COVID-19 pandemic. The study involved a document analysis of protocols and guidelines for ANC provision to evaluate how those changed following the onset of the COVID-19 pandemic and semi-structured interviews with ANC care providers (i.e., gynaecologists and midwives). Results: Guidance was issued by multiple organizations, during the pandemic, on how to approach the risk of infection in pregnant women, recommending several changes to ANC to protect both pregnant women and ANC providers. Both midwives and gynaecologists reported changes in their practice. With less face-to-face consultations happening, digital technologies became critical in the care of pregnant women. Shorter and fewer visits were reported, with midwifery practices adjusting their guidelines further than hospitals. Challenges, with high workloads and lack of personal protective equipment were discussed. Conclusions: The COVID-19 pandemic has had an immense impact on the health care system. This impact has had both negative and positive effects on the provision of ANC in the Netherlands. It is important to learn from the current COVID-19 pandemic and adapt ANC, as well as health care systems as a whole, to be better prepared for future health crises and ensure continuous provision of good quality care.
- Open Access
- 12 January 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1) , e0245155
Hypoxia-induced mitochondrial abnormalities in cells of the placenta
Introduction: Impaired utero-placental perfusion is a well-known feature of early preeclampsia and is associated with placental hypoxia and oxidative stress. Although aberrations at the level of the mitochondrion have been implicated in PE pathophysiology, whether or not hypoxia-induced mitochondrial abnormalities contribute to placental oxidative stress is unknown. Methods: We explored whether abnormalities in mitochondrial metabolism contribute to hypoxia-induced placental oxidative stress by using both healthy term placentae as well as a trophoblast cell line (BeWo cells) exposed to hypoxia. Furthermore, we explored the therapeutic potential of the antioxidants MitoQ and quercetin in preventing hypoxia-induced placental oxidative stress. Results: Both in placental explants as well as BeWo cells, hypoxia resulted in reductions in mitochondrial content, decreased abundance of key molecules involved in the electron transport chain and increased expression and activity of glycolytic enzymes. Furthermore, expression levels of key regulators of mitochondrial biogenesis were decreased while the abundance of constituents of the mitophagy, autophagy and mitochondrial fission machinery was increased in response to hypoxia. In addition, placental hypoxia was associated with increased oxidative stress, inflammation, and apoptosis. Moreover, experiments with MitoQ revealed that hypoxia-induced reactive oxygen species originated from the mitochondria in the trophoblasts. Discussion: This study is the first to demonstrate that placental hypoxia is associated with mitochondrial-generated reactive oxygen species and significant alterations in the molecular pathways controlling mitochondrial content and function. Furthermore, our data indicate that targeting mitochondrial oxidative stress may have therapeutic benefit in the management of pathologies related to placental hypoxia.
- 12 January 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1) , e0245155
Open AccessHypoxia-induced mitochondrial abnormalities in cells of the placenta
Introduction: Impaired utero-placental perfusion is a well-known feature of early preeclampsia and is associated with placental hypoxia and oxidative stress. Although aberrations at the level of the mitochondrion have been implicated in PE pathophysiology, whether or not hypoxia-induced mitochondrial abnormalities contribute to placental oxidative stress is unknown. Methods: We explored whether abnormalities in mitochondrial metabolism contribute to hypoxia-induced placental oxidative stress by using both healthy term placentae as well as a trophoblast cell line (BeWo cells) exposed to hypoxia. Furthermore, we explored the therapeutic potential of the antioxidants MitoQ and quercetin in preventing hypoxia-induced placental oxidative stress. Results: Both in placental explants as well as BeWo cells, hypoxia resulted in reductions in mitochondrial content, decreased abundance of key molecules involved in the electron transport chain and increased expression and activity of glycolytic enzymes. Furthermore, expression levels of key regulators of mitochondrial biogenesis were decreased while the abundance of constituents of the mitophagy, autophagy and mitochondrial fission machinery was increased in response to hypoxia. In addition, placental hypoxia was associated with increased oxidative stress, inflammation, and apoptosis. Moreover, experiments with MitoQ revealed that hypoxia-induced reactive oxygen species originated from the mitochondria in the trophoblasts. Discussion: This study is the first to demonstrate that placental hypoxia is associated with mitochondrial-generated reactive oxygen species and significant alterations in the molecular pathways controlling mitochondrial content and function. Furthermore, our data indicate that targeting mitochondrial oxidative stress may have therapeutic benefit in the management of pathologies related to placental hypoxia.
- 1 July 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (8) , 1039-1040
Authors' reply re: Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset Group B streptococcal disease: a systematic review and meta-analysis
- 1 July 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (8) , 1039-1040
Authors' reply re: Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset Group B streptococcal disease: a systematic review and meta-analysis
- Open Access
- 15 June 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (9) , 1168-1169
Authors' reply re: Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset group B streptococcal disease: a systematic review and meta‐analysis
- 15 June 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (9) , 1168-1169
Open AccessAuthors' reply re: Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset group B streptococcal disease: a systematic review and meta‐analysis